Prostate Cancer Screening
Beginning at age 50, men who have at least a 10-year life expectancy should consider routine prostate screening. Men at high risk (African-American men and men with a strong family history of prostate cancer) could begin testing at age 40. Depending on the results of this initial test, no further testing might be needed until age 45.
The two main screening tools for prostate cancer are the digital rectal examination (DRE) and the prostate-specific antigen (PSA) test, both of which can be administered by your doctor. The DRE and PSA test do not tell if you have cancer but they can indicate if you need further testing.
DRE
The DRE or digital (finger) rectal examination is a quick exam for checking the health of the prostate. For this test, the doctor inserts a gloved and lubricated finger into the rectum. This allows the doctor to feel the back portion of the prostate for size and any irregular or abnormally firm areas.
PSA Test
PSA stands for "prostate-specific antigen." PSA is a substance produced by cells from the prostate gland and released into the blood. The PSA test measures the PSA level in the blood. A small amount of blood is drawn from the arm. The doctor checks the blood to see if the PSA level is normal. The doctor may also use this test to check for any increase in your PSA level compared to your last PSA test.
For more information or to make an appointment please call
1-877-233-WELL (9355).